2-(4-Cyclohexylphenyl)-4-methylmorpholin-2-ol hydrobromide

ID: ALA3623677

PubChem CID: 122192683

Max Phase: Preclinical

Molecular Formula: C17H26BrNO2

Molecular Weight: 275.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Br.CN1CCOC(O)(c2ccc(C3CCCCC3)cc2)C1

Standard InChI:  InChI=1S/C17H25NO2.BrH/c1-18-11-12-20-17(19,13-18)16-9-7-15(8-10-16)14-5-3-2-4-6-14;/h7-10,14,19H,2-6,11-13H2,1H3;1H

Standard InChI Key:  FVLCHQJXUCEVTH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
    5.0632   -3.3641    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    2.3238   -0.1256    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2643   -2.2302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5453   -3.0105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5101   -4.5101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1938   -5.2294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0872   -4.4491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0520   -2.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1586   -6.7297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4384   -7.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4008   -9.0117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0834   -9.7289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1965   -8.9466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1589   -7.4470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  3  9  1  0
  7 10  1  0
  4 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  4  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 13 16  1  0
M  END

Associated Targets(non-human)

Fdft1 Squalene synthetase (891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 275.39Molecular Weight (Monoisotopic): 275.1885AlogP: 2.84#Rotatable Bonds: 2
Polar Surface Area: 32.70Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.99CX Basic pKa: 6.41CX LogP: 3.68CX LogD: 3.64
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.90Np Likeness Score: 0.22

References

1. Ladopoulou EM, Matralis AN, Nikitakis A, Kourounakis AP..  (2015)  Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.,  23  (21): [PMID:26433631] [10.1016/j.bmc.2015.09.034]

Source